[Ed. – The reach of “Trump Truth” is very long.]
A study released Thursday links the use of hydroxychloroquine by COVID-19 patients to lower death rates, as health experts around the country try to find an effective treatment to combat the pandemic.
The study, conducted by Michigan’s Henry Ford Health System, states that hydroxychloroquine, the controversial anti-malarial drug heralded by the White House as a potential treatment for the coronavirus, “significantly” lowered the mortality rate among COVID-19 patients.
In patients who received the drug, the death rate was 13 percent as compared to a death rate of 26.4 percent in patients who weren’t administered the treatment.
“The findings have been highly analyzed and peer-reviewed,” Marcus Zervos, co-author of the study and division head of Infectious Disease for Henry Ford Health System, said in a statement.